Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex, Granting Exclusive Commercialization Rights For ELADYNOS In Mexico, Canada, South Africa, Israel, And Russia, Along With Additional Unpartnered Regions; Radius To Receive Upfront And Milestone Payments Plus Tiered Royalties

Author: Benzinga Newsdesk | December 09, 2024 10:11am

Posted In: RDUS